Biocon advances on reporting 13% rise in Q3 consolidated net profit

22 Jan 2016 Evaluate

Biocon is currently trading at Rs. 489.50, up by 6.55 points or 1.36% from its previous closing of Rs. 482.95 on the BSE.

The scrip opened at Rs. 487.00 and has touched a high and low of Rs. 494.00 and Rs. 476.00 respectively. So far 73,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 544.00 on 05-Jan-2016 and a 52 week low of Rs. 396.50 on 25-Aug-2015.

Last one week high and low of the scrip stood at Rs. 499.70 and Rs. 471.60 respectively. The current market cap of the company is Rs. 9,806.00 crore.

The promoters holding in the company stood at 60.72% while Institutions and Non-Institutions held 19.77% and 17.66% respectively.

The company has registered 19.55% rise in its net profit at Rs 68.5 crore for third quarter ended December 31, 2015 as compared to Rs 57.3 crore for the same quarter in the previous year. Total income of the company has increased 3.25% at Rs 565.3 crore for Q3FY16 as compared Rs 547.5 crore for the corresponding quarter previous year.

On the consolidated basis, the company’s net profit rose 13.31% to Rs 103 crore for the Q3 FY16 as compared to Rs 90.9 crore in Q3 FY15. Moreover, the total income surged 9.90% to Rs 856.1 crore in the quarter under review as compared to Rs 779 crore in the corresponding quarter previous year.


Biocon Share Price

392.80 4.55 (1.17%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×